Average Co-Inventor Count = 3.38
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Glaxosmithkline LLC (6 from 356 patents)
2. Glaxosmithkline Intellectual Property Development Limited (6 from 230 patents)
3. The University of Edinburgh (2 from 168 patents)
4. Dr. Falk Pharma Gmbh (1 from 31 patents)
5. Kynos Therapeutics Limited (0 patent)
15 patents:
1. 12459906 - 3-(5-chloro-2-oxobenzo[d]oxazol-3(2H)-yl) propanoic acid derivatives as KMO inhibitors
2. 11352334 - 3-(5-chloro-2-oxobenzo[d]oxazol-3(2H)-yl) propanoic acid derivatives as KMO inhibitors
3. 10611756 - Method of treating pancreatitis using 1,4-benzoxazine derivatives
4. 10597385 - Prodrug of 1,1'-(1,6-dioxo-1,6-hexanediyl)bis-D-proline
5. 10328052 - D-proline derivatives as SAP depleting agent
6. 10246447 - 3-(6-chloro-3-oxo-3,4-dihydro-(2H)-1,4-benzoxazin-4-yl) propanoic acid derivatives and their use as KMO inhibitors
7. 9873686 - Prodrug of 1,1'-(1,6-dioxo -1,6-hexanediyl)bis-D-proline
8. 9855260 - Quinolinone derivatives
9. 9737505 - Prodrug of 1,1'-(1,6-dioxo-1,6-hexanediyl)bis-D-proline
10. 9701668 - Prodrug of 1,1'-(1,6-dioxo-1,6-hexanediyl)bis-D-proline
11. 9598420 - Benzodiazepine bromodomain inhibitor
12. 9102677 - Benzodiazepine bromodomain inhibitor
13. 9061998 - Quinolinone derivatives
14. 9023842 - Benzodiazepine bromodomain inhibitor
15. 8557984 - Imidazo [4, 5-C] quinoline derivatives as bromodomain inhibitors